The cost of drugs as a percentage of total health care spending has doubled in the last two decades. To reduce the cost of prescription drug plans, governments and health care insurers are beginning to implement programs that attempt to control the costs of reimbursement drugs.

While these programs may reduce expenditures for prescription drugs, patients, physicians, and pharmaceutical companies are concerned these programs focus on reducing drug product costs without regard for patient care. There are additional concerns on the incentives to discover and develop new drugs and medical treatments.

Click here to read the 2003 conference highlights [pdf file]

Is there a balanced solution?

We invite you to join your colleagues on Thursday, April 15, 2004, for "Health Care Policy, a Changing Market, and Prospects for Biotech." Hosted by the Martindale Center in the College of Business and Economics at Lehigh University, this conference will bring together leading pharmaceutical representatives who will address these issues. Seating is limited and we suggest advanced registration.

»Click here for directions«